Candidaemia in Europe: epidemiology and resistance

International Journal of Antimicrobial Agents
A M TortoranoR Grillot

Abstract

Despite the widespread use of antifungals for prophylaxis, Candida bloodstream infection (BSI) remains the most frequent life-threatening fungal disease. From an analysis of multi-institutional surveys of Candida BSIs performed in Europe, including the large prospective survey by the European Confederation of Medical Mycology (2089 episodes from seven countries), a limited role of species with decreased susceptibility to azoles in causing BSIs and a low proportion of antifungal resistance was evident. Large prospective epidemiological surveys using common databases are needed to monitor trends in incidence and changes in species distribution, to identify new at-risk patients and to evaluate the impact of the introduction into the market of new antifungal agents.

Citations

Jun 16, 2007·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·K LagrouE Van Wijngaerden
Jan 22, 2008·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·S Costa-de-OliveiraA Gonçalves Rodrigues
Jan 22, 2008·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·H Hof
Dec 17, 2009·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·D L HornO A Cornely
Feb 14, 2012·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·W A SchellT G Mitchell
Oct 1, 2011·Journal of Food Science and Technology·Maria Leticia EstevinhoXesús Feás
May 15, 2013·International Journal of Antimicrobial Agents·Jad ChahoudSouha S Kanj
May 26, 2009·Revista iberoamericana de micología·Guillermo QuindósElena Eraso
May 26, 2009·Revista iberoamericana de micología·Juan Carlos Pozo-Laderas
Jan 13, 2009·Epidemiology and Infection·D SwinneM Detandt
Jun 15, 2011·Journal of Medicinal Food·Xesús Feás, María L Estevinho
Feb 5, 2013·Omics : a Journal of Integrative Biology·Ashutosh SinghRajendra Prasad
Mar 6, 2010·The Journal of Antimicrobial Chemotherapy·Monica A SlavinUNKNOWN Australian Candidemia Study, Australasian Society for Infectious Diseases
Sep 10, 2010·Current Opinion in Critical Care·Oscar MarchettiThierry Calandra
Aug 17, 2010·Current Opinion in Critical Care·Maiken C Arendrup
Jul 13, 2011·Antimicrobial Agents and Chemotherapy·Anke Burger-KentischerSteffen Rupp
Jun 14, 2012·Journal of Clinical Microbiology·R Teixeira-SantosC Pina-Vaz
Mar 12, 2010·Journal of Clinical Microbiology·Raquel SabinoCélia Pais
Dec 28, 2012·Journal of Clinical Microbiology·Lena Ros AsmundsdottirMagnus Gottfredsson
Aug 23, 2007·BMC Infectious Diseases·Timo HautalaPekka Kujala
Sep 13, 2011·Annals of Intensive Care·Philippe EggimannOscar Marchetti
Apr 12, 2012·Critical Care : the Official Journal of the Critical Care Forum·Mariateresa GiglioFilomena Puntillo
Apr 4, 2012·PloS One·Luciano PolonelliStefania Conti
Nov 26, 2009·Drugs·Claudio Viscoli

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
A M TortoranoECMM Working Group on Candidaemia
Emerging Infectious Diseases
Eira PoikonenPetri Ruutu
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Peter G PappasNIAID Mycoses Study Group
© 2022 Meta ULC. All rights reserved